Condition · 1 treatment path
Macular Degeneration (Wet AMD)
Wet age-related macular degeneration is a form of macular disease in which abnormal leaky blood vessels grow under the central retina. It mainly affects people over 60 and is a leading cause of serious sight loss.
Send your imaging + plan. Board-reviewed opinion in 5–10 working days.
- Treatment paths
- 1Treatment paths
- Specialties
- 1Specialties
- Typical severity
- SevereTypical severity
About macular degeneration (wet amd)
What to know
The first signs are distorted or wavy straight lines, a blurred or dark patch in the centre of vision and difficulty reading or recognising faces, while side vision stays intact. Diagnosis uses an eye examination, optical coherence tomography and sometimes fluorescein angiography. Without prompt treatment, central vision can fall quickly.
Treatment is regular injections into the eye of an anti-VEGF drug such as ranibizumab or aflibercept, which stops the vessels leaking and often stabilises vision. Injections are repeated, often monthly at first, then at longer intervals, with scans to guide timing. Because delay risks lasting sight loss, treatment is started promptly; travel abroad is less practical for long-term care.
Pre-flight workup
Tests to have already done
- Optical coherence tomography (OCT) scans and reports, which show fluid in the retina and are used to judge response to treatment.
- Fundus photographs and fluorescein or OCT angiography reports, if these were done.
- Visual acuity records over time, including the dates of each test.
- A list of previous injections, with the drug used, dates and the response to each.
- A medical history including blood pressure, heart disease, stroke and blood thinners, plus the condition of the other eye.
Second opinion
When to get a second look
- You have had sudden distortion or loss of central vision and have not yet been seen by a retina specialist, which needs urgent assessment.
- Injections are not controlling the fluid and you are told to continue the same drug without a review.
- You have been told treatment is of no use, but your vision has not been assessed by a retina specialist.
- You are unsure whether the diagnosis is wet AMD or another condition such as polypoidal vasculopathy.
Talking to your doctor
Questions to ask
- Is my disease active, and what do my OCT scans show?
- Which anti-VEGF drug is most suitable for me, and how often will I need injections?
- How will you decide whether to continue, extend or change treatment?
- What are the risks of injections, such as infection or raised eye pressure?
- What vision can I realistically keep or regain?
- What should I check at home, and what changes mean I should be seen urgently?
Outlook
Realistic prognosis
Wet AMD can cause rapid loss of central vision if untreated. With anti-VEGF injections, most people keep their existing vision and some regain part of it, particularly when treatment starts early. Injections usually need to continue over months or years, with scans to guide the interval. Scarring or atrophy of the macula limits recovery. Peripheral vision is normally preserved, and the other eye needs regular checks.
01 · Specialties
Specialties that treat Macular
Diagnostic workup
Before you pick a hospital, get the workup right
Picking the right treatment is downstream of a complete diagnosis. Skip steps here and the destination surgeon usually re-orders them anyway — at higher cost and another week on the ground.
- Confirm the diagnosis on imaging or labs
For macular degeneration (wet amd), plan on the workup your home doctor would order anyway — typically a recent specialist consult plus the imaging / labs the destination team will need to quote accurately. Anything older than 90 days usually gets re-done.
- See a ophthalmology specialist locally first
An in-person clinical exam at home — even a single consult — costs little and dramatically improves the destination plan. Bring back: written impression, recommended procedure, surgical-risk class, and any contra-indications.
- Send us the file for a free second opinion
Two surgeons in our medical panel review the workup independently. They tell you whether they'd operate, watch, or refer — even if that means recommending against travel.
- Pick a path with timeline + cost in writing
Once a treatment is the right call, we line up 2–3 hospital options with itemized quotes, surgeon profiles, and a travel timeline. You hold the file — switch hospitals or step away at any point.
03 · Treatment paths
Treatment options
Where to be treated
Macular Degeneration (Wet AMD) treatment by destination
04 · FAQ
Common questions about macular degeneration (wet amd)
Is wet AMD curable?
No, but injections can control it and protect vision.
How many injections will I need?
Usually a monthly loading series, then spaced intervals, often continuing for years.
Will I go blind?
Central vision can be badly affected, but peripheral vision is normally kept.
Can I fly while on treatment?
Yes. Plan travel around injection dates, because delays can allow the disease to worsen.
Clinical context
Working up macular degeneration (wet amd) properly
A condition like macular degeneration (wet amd) is rarely well-served by jumping straight to treatment shopping. The sequence below is what a ophthalmology specialist would expect to see completed — and the absence of any step is the right cue to delay travel decisions.
Diagnostic workup, in sequence
- First-line clinical assessment
History, physical exam, and risk-factor review by a senior generalist or ophthalmology specialist. Symptoms list, family history, prior workup notes, and current medication list should travel with the patient.
- Standard imaging + labs
Baseline blood work, condition-specific imaging (ultrasound / X-ray / MRI / CT — depending on indication), and ECG / pulmonary function as relevant. Bring digital copies of any prior imaging — saves repeat scans and the cost that goes with them.
- Specialist diagnostic workup
Procedure-specific tests — biopsy, cardiac catheterisation, endoscopy, or genetic / molecular profiling depending on the suspected diagnosis. Done at the centre that will treat, ideally, so results integrate cleanly into the treatment plan.
- Multidisciplinary review (where indicated)
Cancer, complex cardiac, transplant, and rare-disease cases should be reviewed by a multidisciplinary panel — surgical, medical, imaging, and pathology — before any treatment commits. Single-discipline plans for complex disease are a quality red flag.
When to escalate urgently
- Acute worsening of established symptoms — sudden chest pain, shortness of breath at rest, neurological deficit, severe bleeding, persistent high fever.
- Loss of consciousness, severe persistent vomiting, or any focal neurological event.
- Symptoms in the early hours of onset that fit a time-sensitive treatment window (stroke, MI, sepsis) — every hour costs outcome.
- If you are travelling internationally for treatment and develop these symptoms in transit, divert to the nearest emergency department; do not wait to reach the planned destination.
Before you book international travel
- Confirm your specific diagnosis is fully worked up before you commit to a treatment plan abroad. Travelling for the workup is fine; travelling for treatment without the workup done is not.
- Get your case reviewed remotely by the destination centre's team before you book flights — credible international patient programs review imaging + reports before they confirm the surgical plan.
- Bring a digital + physical copy of your full medical record: imaging on USB drive in DICOM format, labs in PDF, current medication list with dosages, allergies, and any prior surgical reports.
- Plan for the post-op rehabilitation phase before you fly — the surgery itself is rarely the bottleneck.
- Confirm that follow-up imaging and any necessary in-person reviews can be done at home — a treatment plan that requires repeat international trips is more burdensome (and more expensive) than the headline procedure.
Methodology and editorial standards
This macular degeneration (wet amd) overview is written by the editorial team from published Ophthalmology sources and lists 1 treatment options offered by hospitals on our network. The page shows its last-updated date. Clinical descriptions are editorial — your treating clinician confirms what's right for your specific case.
- Hospital data. Hospital details are compiled from public sources and hospital websites. Accreditation (JCI, NABH and others) is shown where we hold a record of it. Always ask the hospital for its current certificate.
- Doctor credentials. Qualifications, specialty and bio come from the doctor's hospital profile. Licence is checked against the national medical-council register only where the profile shows a "Licence verified" badge with a date.
- Prices. Price ranges are indicative, compiled from hospital price lists and packages and shown with the date last updated. The hospital's written quote is what you pay against.
- Clinical text. Written by the Medcasts editorial team from published clinical sources. Unless a named reviewer is shown on the page, it has not been reviewed by a doctor.
- Independence. Hospitals cannot pay to change their position on our pages.
Macular Degeneration (Wet AMD)
Continue evaluating macular degeneration (wet amd) care
Condition overview is one entry. These hubs route the same care decision via specialty, surgeon, treatment, and destination — including the doctors actively treating macular degeneration (wet amd).
- Surgeons Doctors treating Macular Degeneration (Wet AMD) Volume-ranked specialists across all relevant specialties.
- Specialty Ophthalmology hub Programs, surgeons, hospitals across ophthalmology.
- Procedure Anti-VEGF Injection (Lucentis / Eylea) First-line treatment with success rates, recovery, hospital pricing.
- Browse All 79 conditions Map condition → specialty → first-line treatment.
- Browse 9 destination countries Cost-of-care profiles, hospital programs, visa playbooks.
- Compare Hospital comparison Side-by-side accreditations, ratings, beds, and pricing.
- Compare Doctor comparison Surgeons compared on volume, fees, languages, video-consult availability.
- Tool Match-me triage Three questions, get a specialty + destination + 3-hospital shortlist.
- Tool Cost calculator Hospital-reported pricing across procedures × destinations.
- Action Free second opinion Independent panel review of your case in 48 hours — no charge.
Next step · Macular Degeneration (Wet AMD)
Free second opinion on your Macular case.
Share imaging and the current plan. Multidisciplinary board returns a written opinion within 5–10 working days — no obligation to travel.